HOME >> MEDICINE >> NEWS
Clinical trial participants fare no better, no worse than other patients

People who participate in randomized controlled studies to test new therapies seem to fare no better or no worse than those who receive the same care outside of such studies, a new review of research has found.1

The finding was published against a backdrop of debate about drug trials for popular pain-relievers and about whether trial results can be safely applied to an entire population. "These results challenge the assertion that the results of RCTs (randomized controlled trials) are not applicable to usual clinical practice," report the authors, who say this review is the most comprehensive of its kind conducted to date.

A randomized clinical trial is considered the "gold standard" of medical research because it is the best way to make sure that the only difference between the groups that are compared is the treatment they receive. Patients are assigned to each group randomly in order to increase the probability that differences between the groups can be attributed only to the treatment under study.

Critics, however, say the rigorous standards for inclusion in trials and the nature of those who conduct and participate in them mean that when a new drug or treatment is applied to a general population, the results might be different.

A recent article in the prestigious journal The Lancet suggested that clinical trials cannot be expected to be relevant to all patients with the same conditions for a number of reasons, such as selecting trial participants who are in better overall health, excluding people who have conditions in addition to the one being studied and the reality that in a general population patients will not always act according to doctors' instructions.

In the new study, researchers led by Gunn Elisabeth Vist of the Norwegian Health Services Research Centre, systematically identified and reviewed 55 studies involving a total of more than 31,000 patients who were treated in randomized clinical trials an
'"/>

Contact: GE Vist
gev@nhscr.no
Center for the Advancement of Health
23-Jan-2005


Page: 1 2 3

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
4. National Academies news: Clinical research involving children
5. Clinical research key in advance to prospective health care
6. Clinical trial of new TB vaccine begins
7. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
8. Clinical factors useful to identify heart failure patients with high risk of death
9. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
10. $7 million grant continues Asthma Clinical Research Network efforts
11. Clinical study of Penn State Hershey technology begins in South Africa

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clinical trial participants fare better worse than other patients

(Date:11/21/2014)... First Choice Emergency Room ... new facility is located at 225 E. Parkwood Drive, ... are pleased to join the Friendswood community and look ... here,” said Dr. Siddiqi, Facility Medical Director of First ... the opening, First Choice Emergency Room made a donation ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 M3 Global ... verified healthcare professional panel, today announced two important leadership changes ... Roni DasGupta as President of Market Research, Americas and the ... Europe. , Ms. DasGupta joined M3 in 2011 ... most recently Head of Sales. Roni has over 17 ...
(Date:11/21/2014)... By Dennis Thompson ... -- Overweight or obese women who get pregnant are much ... disease as an adult, new research suggests. But it ... in that trend, the researchers added. "Mothers who are ... study author Dr. Michael Mendelson. He is a research fellow ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Some people with cochlear ... internal magnet when they undergo an MRI scan, a ... by the researchers, about 300,000 people worldwide have cochlear ... people who are deaf or have severe hearing loss. ... with cochlear implants when undergoing MRI. One expert ...
(Date:11/21/2014)... By Serena Gordon ... -- Two U.S. government agencies have proposed new rules ... a clinical trial was successful or not. The ... required to publish summaries of their results to ClinicalTrials.gov -- ... of Health (NIH) and the U.S. Department of Health and ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2Health News:Kids Born to Overweight Moms May Face Higher Heart Risks as Adults 2Health News:MRI Can Be Painful, Disruptive for People With Cochlear Implants 2Health News:U.S. Proposes Greater Public Access to Data From Clinical Trials 2
(Date:11/18/2014)... , Nov. 18, 2014  NxStage ® ... leading manufacturer of innovative dialysis products , ... Express dialyzer for the in-center, hemodialysis market. ... which is designed to reduce the amount of ... the number of touch point contamination sites.  The ...
(Date:11/18/2014)... N.J. , Nov. 18, 2014 ... 230,000 American women this year who get a ... today announced new resources for case managers to ... and 5—to navigate the myriad physical, emotional and ... resources are available at no cost via the ...
(Date:11/18/2014)... , Nov. 18, 2014  TransCelerate BioPharma ... most recent manuscript on Risk-Based Monitoring (RBM), ... Quality Control Measure in Clinical Trials ," ... Innovation & Regulatory Science  (TIRS) journal. Developed ... with Medidata, the manuscript examines the value ...
Breaking Medicine Technology:NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3
Cached News: